RRC ID 1428
Author Miyano J, Yamamoto S, Hanioka N, Narimatsu S, Ishikawa T, Ogura K, Watabe T, Nishimura M, Ueda N, Naito S.
Title Involvement of SULT1A3 in elevated sulfation of 4-hydroxypropranolol in Hep G2 cells pretreated with beta-naphthoflavone.
Journal Biochem Pharmacol
Abstract Pretreatment of Hep G2 cells with beta-naphthoflavone (BNF 1-25microM) significantly increased cytosolic sulfation activities of 4-hydroxypropranolol (4-OH-PL) racemate. The profile was similar to those of sulfations towards dopamine and triiodothyronine in the same cytosolic fractions. Kinetic studies of 4-OH-PL sulfation in Hep G2 cytosolic fractions revealed that V(max) values increased but apparent K(m) values remained unchanged following the BNF pretreatment. Among five recombinant human SULT isoforms (SULT1A1, -1A3, -1B1, -1E1 and -2A1) examined, only SULT2A1 did not show 4-OH-PL sulfation activities under the conditions used. SULT1A3 and -1E1 exhibited an enantioselectivity of 4-OH-R-PL sulfation>4-OH-S-PL sulfation, which agreed with that of BNF-pretreated Hep G2 cells as well as of nontreated cells, whereas SULT1A1 and -1B1 showed a reversed enantioselectivity (R
Volume 69(6)
Pages 941-50
Published 2005-3-15
DOI 10.1016/j.bcp.2004.12.012
PII S0006-2952(05)00004-3
PMID 15748705
MeSH Arylsulfotransferase Cell Line Dose-Response Relationship, Drug Humans Isoenzymes / biosynthesis Isoenzymes / genetics Propranolol / analogs & derivatives* Propranolol / metabolism* Sulfates / metabolism Sulfotransferases / biosynthesis* Sulfotransferases / genetics beta-Naphthoflavone / pharmacology*
IF 4.96
Times Cited 16
WOS Category PHARMACOLOGY & PHARMACY
Resource
Human and Animal Cells Hep G2